Completed NA INTERVENTIONAL 2-arm NCT05836181

The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient. (EMDR)

The Effect of Eye Movement Desensitization and Reprocessing Reducing Anxiety, Depressive Symptoms, Blood Pressure, and Heart Rate Variability in Primary Hypertension： A Randomized Controlled Clinical Trial

Sponsor: Miao-Yi Chen

Conditions Anxiety Blood Pressure Eye Movement Desensitization and Reprocessing Intervention Heart Rate Variability

Interventions Eye Movement Desensitization and Reprocessing

Updated 3 times since 2023 Last updated: Apr 18, 2023 Started: Feb 1, 2014 Primary completion: Dec 10, 2016 Completion: Dec 28, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05836181, this NA trial focuses on Anxiety and Blood Pressure and remains completed. Sponsored by Miao-Yi Chen, it has been updated 3 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Miao-Yi Chen

Data source: National Defense Medical Center, Taiwan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan